Japan Nuclear Medicines Market (2025-2031) | Companies, Drivers, Competition, Segmentation, Analysis, Growth, Outlook, Pricing Analysis, Revenue, Opportunities, Trends, Share, Restraints, Size, Strategy, Challenges, Segments, Competitive, Supply, Industry, Value, Investment Trends, Strategic Insights, Forecast, Consumer Insights, Demand

Market Forecast By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application Area (Oncology Imaging, Thyroid Treatment, Cardiac Imaging, Bone Pain Palliation), By End User (Hospitals, Endocrinology Clinics, Cardiology Centers, Cancer Treatment Centers), By Product Type (Technetium-99m, Iodine-131, Thallium-201, Samarium-153) And Competitive Landscape
Product Code: ETC12702610 Publication Date: Apr 2025 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Sachin Kumar Rai No. of Pages: 65 No. of Figures: 34 No. of Tables: 19

Key Highlights of the Report:

  • Japan Nuclear Medicines Market Outlook
  • Market Size of Japan Nuclear Medicines Market,2024
  • Forecast of Japan Nuclear Medicines Market, 2031
  • Historical Data and Forecast of Japan Nuclear Medicines Revenues & Volume for the Period 2021-2031
  • Japan Nuclear Medicines Market Trend Evolution
  • Japan Nuclear Medicines Market Drivers and Challenges
  • Japan Nuclear Medicines Price Trends
  • Japan Nuclear Medicines Porter's Five Forces
  • Japan Nuclear Medicines Industry Life Cycle
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Type for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Diagnostic Radiopharmaceuticals for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Therapeutic Radiopharmaceuticals for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Application Area for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Oncology Imaging for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Thyroid Treatment for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Cardiac Imaging for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Bone Pain Palliation for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By End User for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Hospitals for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Endocrinology Clinics for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Cardiology Centers for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Cancer Treatment Centers for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Product Type for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Technetium-99m for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Iodine-131 for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Thallium-201 for the Period 2021-2031
  • Historical Data and Forecast of Japan Nuclear Medicines Market Revenues & Volume By Samarium-153 for the Period 2021-2031
  • Japan Nuclear Medicines Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Application Area
  • Market Opportunity Assessment By End User
  • Market Opportunity Assessment By Product Type
  • Japan Nuclear Medicines Top Companies Market Share
  • Japan Nuclear Medicines Competitive Benchmarking By Technical and Operational Parameters
  • Japan Nuclear Medicines Company Profiles
  • Japan Nuclear Medicines Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Japan Nuclear Medicines Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Japan Nuclear Medicines Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Japan Nuclear Medicines Market Overview

3.1 Japan Country Macro Economic Indicators

3.2 Japan Nuclear Medicines Market Revenues & Volume, 2021 & 2031F

3.3 Japan Nuclear Medicines Market - Industry Life Cycle

3.4 Japan Nuclear Medicines Market - Porter's Five Forces

3.5 Japan Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Japan Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F

3.7 Japan Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F

3.8 Japan Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F

4 Japan Nuclear Medicines Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer and other chronic diseases in Japan leading to higher demand for nuclear medicines.

4.2.2 Technological advancements in nuclear medicine imaging techniques improving diagnostics and treatment outcomes.

4.2.3 Growing investments in healthcare infrastructure and research and development in the field of nuclear medicine in Japan.

4.3 Market Restraints

4.3.1 Stringent regulations and safety concerns associated with nuclear medicines leading to higher production costs and limited market approvals.

4.3.2 High initial investment and operational costs for setting up nuclear medicine facilities.

4.3.3 Limited availability of skilled professionals and expertise in the field of nuclear medicine in Japan.

5 Japan Nuclear Medicines Market Trends

6 Japan Nuclear Medicines Market, By Types

6.1 Japan Nuclear Medicines Market, By Type

6.1.1 Overview and Analysis

6.1.2 Japan Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F

6.1.3 Japan Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F

6.1.4 Japan Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F

6.2 Japan Nuclear Medicines Market, By Application Area

6.2.1 Overview and Analysis

6.2.2 Japan Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F

6.2.3 Japan Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F

6.2.4 Japan Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F

6.2.5 Japan Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F

6.3 Japan Nuclear Medicines Market, By End User

6.3.1 Overview and Analysis

6.3.2 Japan Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F

6.3.3 Japan Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F

6.3.4 Japan Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F

6.3.5 Japan Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F

6.4 Japan Nuclear Medicines Market, By Product Type

6.4.1 Overview and Analysis

6.4.2 Japan Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F

6.4.3 Japan Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F

6.4.4 Japan Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F

6.4.5 Japan Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F

7 Japan Nuclear Medicines Market Import-Export Trade Statistics

7.1 Japan Nuclear Medicines Market Export to Major Countries

7.2 Japan Nuclear Medicines Market Imports from Major Countries

8 Japan Nuclear Medicines Market Key Performance Indicators

8.1 Average time taken for regulatory approvals for new nuclear medicine products in Japan.

8.2 Number of research publications and clinical trials related to nuclear medicines in Japan.

8.3 Percentage of hospitals and medical facilities in Japan offering nuclear medicine imaging services.

9 Japan Nuclear Medicines Market - Opportunity Assessment

9.1 Japan Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Japan Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F

9.3 Japan Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F

9.4 Japan Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F

10 Japan Nuclear Medicines Market - Competitive Landscape

10.1 Japan Nuclear Medicines Market Revenue Share, By Companies, 2024

10.2 Japan Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence